ELKTON, Md., June 24 /PRNewswire/ -- Greg Tronto, Business Leader for Single Use Bioprocess Components at W. L. Gore & Associates, was named to the Delaware BioScience Association board of directors.
The Delaware BioScience Association brings together representatives from organizations in life sciences including pharmaceutical and biotechnology firms, medical device manufacturers, agricultural biotech and chemical companies, research and testing companies, hospitals and medical institutions, and other organizations and related services companies with the shared goal of expanding the bioscience economy.
“I am pleased that the Delaware BioScience Association will benefit from the breadth and depth of innovation and business-building experience that Greg Tronto brings to the table,” said Bob Dayton, president of the Delaware BioScience Association. “The addition of Greg and Gore PharmBIO Products strengthens our ability to be the catalyst for a cohesive biotechnology community in the Mid-Atlantic region.”
One of the organizations’ goals is to advance public understanding of the role that the bioscience industry plays in shaping the future of healthcare; in developing drugs, vaccines, devices and diagnostics that save and improve the lives of patients, in promoting the quality of life worldwide; and in contributing to the local, national and global communities and economies.
“I am honored to be part of this dynamic and collaborative organization whose vision is consistent with my experience and passion,” said Tronto. “I’m looking forward to working with this phenomenal group of industry-leading board members to forward the mission of the Delaware BioScience Association.”
About Greg Tronto
Tronto, 44, has earned a reputation as an innovative business builder in the biopharmaceutical marketplace. He has a proven track record of establishing and leading high-growth, high-profit ventures as well as identifying and creating market value and market advantage for new and existing technologies.
Since joining W. L. Gore & Associates in 1988, Tronto has launched and led several successful business ventures. He is currently the Business Leader for Single Use Bioprocess Components of Gore PharmBIO Products. He’s charged with building and leading a global, cross-functional team focused on maximizing growth opportunities in the biotechnology and pharmaceutical industries.
Tronto holds a US Filter patent 5,207,812, Tronto et. al., co inventor, 1995. He’s authored industry white papers and has been a presenter at leading industry trade events and forums. Tronto has a BS in mechanical engineering from Widener University in Chester, PA. A resident of Hockessin, DE, Tronto is married with two children.
About The Delaware BioScience Association
Established in 2006, The Delaware BioScience Association is a non-profit trade association that serves its members by collaborating with local businesses and organizations to advance the growth of the bioscience industry in Delaware and the Mid-Atlantic region.
As one of over 35 state affiliates of the Biotechnology Industry Organization (BIO), the organization and its members benefit from the ability to share best practices across the country and from gaining a stronger voice for influencing the legislative landscape for future growth.
The association partners with community and national-level bioscience organizations to build a sustainable bioscience economy through advocacy, policy and guidelines development as well as education and awareness initiatives.
The Delaware BioScience Association board of directors includes J. Michael Bowman, chairman & president, Delaware Technology Park; Patricia Cannon, Healthcare market leader, Delaware Economic Development Office; Andrew Cottone, Ph.D., vice president, chemistry, Adesis, Inc.; Fran DiNuzzo, executive vice president, chief business officer, Strategic Diagnostics, Inc.; Jennifer Kmiec, vice president, business development and marketing, InB:Biotechnologies, Inc.; Matthew H. Knight, president and CEO, Strategic Diagnostics, Inc.; John P. Ranieri, Ph.D., vice president and manager, DuPont Bio-Based Materials; Hazell Reed, Ph.D., senior administration for research, Delaware State University; Helen Stimson, Vice President & General Manager Columns and Supplies Solutions LSCA Agilent Technologies, Inc.; David S. Weir, Ph.D., director, Delaware Biotechnology Institute; Ian Wright, head of global assay development, Siemens Healthcare Diagnostics and Christopher Yochim, associate director external relations, SPBD, AstraZeneca Pharmaceuticals.
About W. L. Gore & Associates, Inc.
W. L. Gore & Associates, Inc. is a worldwide presence, providing diverse, high-performance solutions in pharmaceutical, consumer, industrial, electronic, medical and surgical markets.
For 50 years, W. L. Gore & Associates has cultivated a unique corporate culture, resulting in a high-energy commitment to innovation and a passionate belief in making a difference.
Gore, perhaps best known as the inventors of ePTFE and the makers of GORE-TEX(R) fabric, is a leading manufacturer of thousands of advanced technology products. With annual sales of over $2 billion, Gore today claims a manufacturing or sales presence in more than 80 countries and employs more than 8,000 associates in 45 facilities throughout the world. Gore is one of only three companies included in every selection of Fortune Magazine’s “100 Best Companies to Work For” since the list began in 1984. The company is celebrating its 50th anniversary in 2008.
Within the Enterprise, Gore PharmBIO Products is focused on fueling the ongoing development of high-performance, technology-driven products and applications to better serve customers in the global pharmaceutical and bioprocess markets.
For more information about W. L. Gore & Associates, Inc. and Gore PharmBIO Products, call 1-800/1-888-914-GORE(4673), or visit http://www.gore.com/pharmbio.
CONTACT: Jane Haseldine of Delaware BioScience Association,
+1-302-452-1104; or Liane Adduci, +1-312-994-2451, or Brad Drew,
+1-312-994-2452, both for W. L. Gore & Associates
Web site: http://www.gore.com/pharmbio/
